If healthcare professionals suspect HAE, laboratory testing is necessary to confirm the diagnosis. This usually involves a blood test to check for levels of two types of proteins found in your ...

Type I HAE, which accounts for approximately 85% of cases, occurs due to a genetic mutation leading to a reduced quantity of secreted functional C1-INH. 1,7 In type II HAE, which occurs in ...

HAE is a rare genetic disorder estimated to affect about 1 in 10,000 to 1 in 50,000 people worldwide that can result in unpredictable and potentially life-threatening recurring attacks of ...

CARLSBAD, Calif., February 20, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus ...